Patterns of Drug Resistance Parameters in Adult Leukemia

References

• Vendrik C. P. J., Bergers J.J., Dejong W.H., Steerenberg P.A. Resistance to Cytostatic Drugs at the Cellular Level. Cancer Chemother. Pharmacol. 1992; 29(6): 413–429
   Web of Science ®Google Scholar
• Juliano R.L., Ling V.A. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta. 1976; 455: 152–162
   PubMed Web of Science ®Google Scholar
• Ling V. P-Glycoprotein and Resistance to Anticancer Drugs (Reprinted from Accomplishments in Cancer Research, Pg. 79, 1991). Cancer 1991; 69(10)2603–2609
   Web of Science ®Google Scholar
• Roninson I.B. The Role of the MDR1 (P-Glycoprotein) Gene in Multidrug Resistance in Vitro and in Vivo. Biochem. Pharmacol. 1992; 43(1)95–102
   PubMed Web of Science ®Google Scholar
• Koberda J., Hellmann A. Glutathione S-Transferase Activity of Leukemic Cells as a Prognostic Factor for Response to Chemotherapy in Acute Leukemias. Med. Oncol & Tumor Pharmacother. 1991; 8(1)35–38
   PubMedGoogle Scholar
• Tidefelt U., Elmhornrosenborg A., Paul C., Hao X.Y., Mannervik B., Eriksson L.C. Expression of Glutathione Transferase-pi as a Predictor for Treatment Results at Different Stages of Acute Nonlymphoblastic Leukemia. Cancer Res. 1992; 52(12): 3281–3285
   Web of Science ®Google Scholar
• Suzukake K., Petro B., Vistica D.T. Reduction in glutathione content of L-PAM resistent L1210 cells confers drug sensitivity. Biochem. Pharmacol. 1982; 31: 121–124
   PubMed Web of Science ®Google Scholar
• Crook T.R., Sonhami R.L., Whyman G.D., McLean A. E. M. Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide. Cancer Res. 1986; 46: 5035–5038
   PubMed Web of Science ®Google Scholar
• Kramer R.A., Zakher J., Kim G. Role of Glutathione Redox Cycle in Acquired and de Novo Multidrug Resistance. Science 1988; 241: 694–697
   PubMed Web of Science ®Google Scholar
• Arrick B.A., Nathan C.F. Glutathione Metabolism as a Determinant of Therapeutic Efficacy: AReview. Cancer Res. 1984; 44: 4224–4232
   PubMed Web of Science ®Google Scholar
• Black S.M., Wolf C.R. The role of glutathione-de-pendent enzymes in drug resistance. Pharmacol Ther. 1991; 51: 139–154
   PubMed Web of Science ®Google Scholar
• Redmond S. M. S., Joncourt F., Buser K., Ziemiecki A., Altermatt H.J., Fey M., Margison G., Cerny T. Assessment of P-glycoprotein, glutathione-based detoxifying enzymes and 06-alky 1-guanine-DNA-alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumors. Cancer Res. 1991; 51: 2092–2097
   PubMed Web of Science ®Google Scholar
• Carmichael J., Forrester L.M., Lewis A.D., Hayes J.D., Hayes P.C., Wolf C.R. Glutathione-S-transferase isoenzymes and glutathione peroxidase activity in normal and tumour samples from human lung. Carcinogenesis 1988; 9(9)1617–1621
   PubMed Web of Science ®Google Scholar
• Di Ilio C., Del Boccio G., Casaccia R., Aceto A., Di Giacomo F., Federici G. Selenium level and glutathione-dependent enzyme activities in normal and neoplastic human lung tissues. Carcinogenesis 1987; 8(2)281–284
   PubMed Web of Science ®Google Scholar
• Howie A.F., Forrester L.M., Glancey M.J., Schlager J.J., Powis G., Beckett G.J., Hayes J.D., Wolf C.R. Glutathione-S-transferase and glutathione peroxidase expression in normal and tumour human tissues. Carcinogenesis 1990; 11(3): 451–458
   Web of Science ®Google Scholar
• Pegg A.E., Byers T.L. Repair of DNA Containing 06-Alkylguanine. FASEBJ. 1992; 6(6)2302–2310
   PubMed Web of Science ®Google Scholar
• D'Incalci M., Citti L., Taverna P., Catapano C.V. Importance of the DNA repair enzyme 06-alkylguanine alkyl transferase (AT) in cancer chemotherapy. Cancer Treat. Rev. 1988; 15: 279–292
   PubMed Web of Science ®Google Scholar
• Fujio C., Chang H.R., Tsujimura T., Ishizaki K., Kitamura H., Ikenaga M. Hypersensitivity of human tumor xenografts lacking 06-Alkylguanine-DNA-alkyltransferase to the anti-tumor agent (1-(4-amino-2-methyl-5-pyrimidiny 1)methyl-3-(2-chloro-ethyl)-3-nitrosourea. Carcinogenesis 1989; 10: 351–356
   PubMed Web of Science ®Google Scholar
• Trey J.E., Gerson S.L. The role of 06-Alkylguanine-DNA Alkyltransferase in limiting nitrosourea-induced sister chromatid exchanges in proliferating human lymphocytes. Cancer Res. 1989; 49: 1899–1903
   PubMed Web of Science ®Google Scholar
• Tagliabue G., Citti L., Massazza G., Damia G., Giavazzi R., Dincalci M. Tumour of Levels of 06-Alkylguanine-DNA-Alkyltransferase and Sensitivity to BCNU of Human Xenografts. Anticancer Res. 1992; 12(6B)2123–2126
   PubMed Web of Science ®Google Scholar
• Gerson S.L., Berger N.A., Arce C., Petzoid S.J., Willson J. K. V. Modulation of Nitrosourea Resistance in Human Colon Cancer by 06-Methylguanine. Biochem. Pharmacol. 1992; 43(5)1101–1107
   PubMed Web of Science ®Google Scholar
• Joncourt F., Oberli A., Redmond S. M. S., Fey M.F., Tobler A., Margison G.P., Gratwohl A., Buser K., Cerny T. Cytostatic Drug Resistance-Parallel Assessment of Glutathione-Based Detoxifying Enzymes, 06-Alkylguanine-DNA-Alkyltransferase and P-Glycoprotein in Adult Patients with Leukaemia. Br. J. Haematol. 1993; 85(1)103–111
   PubMed Web of Science ®Google Scholar
• Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Annals Biochem. 1969; 27: 502–522
   Web of Science ®Google Scholar
• Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-Transferase: the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974; 249(22)7130–7139
   PubMed Web of Science ®Google Scholar
• Gunzler W.A., Kremers H., Flohé L. An Improved Coupled Test Procedure for Glutathione Peroxidase (EC 1.11.1.9.) in Blood. Z. Klin. Chem. Klin. Biochem. 1974; 12: 4444–4448
   Google Scholar
• Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Annals Biochem. 1976; 72: 248–254
   Web of Science ®Google Scholar
• Morten J. E. N., Margison G.P. Increased 06-Alkylguanine Alkyltransferase Activity in Chinese Hamster V79 Cells following Selection with Chloroethylating Agents. Carcinogenesis 1988; 9(1)45–49
   PubMed Web of Science ®Google Scholar
• Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680
   PubMed Web of Science ®Google Scholar
• Ito Y., Tanimoto M., Kumazawa T., Okumura N., Morihima Y., Ohno R., Saito H. Increased P-glycoprotein expression and multidrug-resistant gene (mdr1) amplification are infrequently found in fresh acute leukemia cells. Cancer 1989; 63: 1534–1538
   PubMed Web of Science ®Google Scholar
• Chitnis M., Hegde U., Chavan S., Juvekar A., Advani S. Expression of the Multidrug Transporter P-Glycoprotein and In vitro Chemosensitivity-Correlation with In vivo Response to Chemotherapy in Acute Myeloid Leukemia. Select. Cancer Ther. 1991; 7(4)165–173
   PubMedGoogle Scholar
• Musto P., Melillo L., Lombardi G., Matera R., Di Giorgio G., Carotenuto M. High risk of early resistant relapse for leukaemic patients with presence of multidrug resistance associated P-glycoprotein positive cells in complete remission. Br. J. Haematol. 1991; 77: 50–53
   PubMed Web of Science ®Google Scholar
• Pirker R., Wallner J., Geissler K., Linkesch W., Haas O.A., Bettelheim P., Hopfner M., Scherrer R., Valent P., Havelec L. Mdr1 gene expression and treatment outcome in acute myeloid leukemia. J. Natl. Cancer Inst. 1991; 83(10)708–712
   PubMed Web of Science ®Google Scholar
• Marie J.P., Zittoun R., Sikic B.I. Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitive. Blood 1991; 78(3)586–592
   PubMed Web of Science ®Google Scholar
• Gruber A., Vitols S., Norgren S., Arestrom I., Peterson C., Bjorkholm M., Reizenstein P., Luthman H. Quantitative Determination of mdrl Gene Expression in Leukaemic Cells from Patients with Acute Leukaemia. Br. J. Cancer. 1992; 66(2)266–272
   PubMed Web of Science ®Google Scholar
• Cumber P.M., Jacobs A., Hoy T. J. F., Whittaker J.A., Tsuruo T., Padua R.A. Expression of the multiple drug resistance gene (mdr-1) and epitope masking in chronic lymphatic leukaemia. Br. J. Haematol. 1990; 76: 226–230
   PubMed Web of Science ®Google Scholar
• Zhou D.C., Marie J.P., Suberville A.M., Zittoun R. Relevance of mdr1 Gene Expression in Acute Myeloid Leukemia and Comparison of Different Diagnostic Methods. Leukemia 1992; 6(9)879–885
   PubMed Web of Science ®Google Scholar
• Gekeler V., Frese G., Noller A., Handgretinger R., Wilisch A., Schmidt H., Muller C.P., Dopfer R., Klingebiel T., Diddens H. Mdr1/P-Glycoprotein, Topoisomerase, and Glutathione-S-Transferase-pi Gene Expression in Primary and Relapsed State Adult and Childhood Leukaemias. Br. J. Cancer 1992; 66(3)507–517
   PubMed Web of Science ®Google Scholar
• Willman C.L., Kopecky K.J., Weick J., Applebaum F., Grever M.R., Head D.R., Elias L., Balcerzak S.P., Mills G.M., Hynes H.E. Biologic parameters that predict treatment response in de novo acute myeloid leukaemia (AML): CD34 but not multidrug resistance (mdr) gene expression is associated with a decreased complete remission (CR) rate and CD34+ patients more frequently achieve CR with high dose cytosine arabinoside. Proc. ASCO 1992; 11: A262
   Google Scholar
• Ball E.D., Lawrence D., Malnar M., Ciminelli N., Mayer N., Wurster-Hill D., Davey F.R., Bloomfield C.D. Correlation of CD34 and multi-drug resistance P170 with FAB and cytogenetics but not prognosis in acute myeloid leukemia (AML). Blood 1990; 76: 252a
   Google Scholar
• Sargent J., Elgie A., Talor C., Faulkner-Pulsford J. Resistance patterns of anthracycline analogues in acute myeloid leukemia (AML) using the MTT assay. Drug resistance in leukemia and lymphoma, G. J. L. Kaspers, R. Pieters, P.R. Twentyman, L.M. Weisenthal, A. J. P. Veerman. Harwood academic publishers. 1993; 285–297
   Google Scholar
• Ubezio P., Limonta M., D'Incalci M., Damia G., Masera G., Giudici G., Wolverton J.S., Beck W.T. Failure to detect the P-Glycoprotein Multidrug-Resistant phenotype in cases of resistant childhood acute lymphocytic leukemia. Eur. J. Cancer Clin. Oncol. 1990; 25(12)1895–1899
   Google Scholar
• Campos L., Guyotat D., Archimbaud E., Calmard-Oriol P., Tsuruo T., Troncy J., Treille D., Fiere D. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 1992; 79(2)473–476
   PubMed Web of Science ®Google Scholar
• Sato H., Preisler H., Day R., Razo A., Larson R., Browman G., Goldberg J., Vogler R., Grunwald H., Gottlieb A. Mdr1 transcript levels as an indication of resistant disease in acute myelogenous leukemia. Br. J. Haematol. 1990; 75: 340–345
   PubMed Web of Science ®Google Scholar
• Michieli M., Damiani D., Geromin A., Michelutti A., Fanin R., Raspadori D., Russo D., Visani G., Dinota A., Pileri S. Overexpression of Multidrug Resistance-Associated pi 70-Glycoprotein in Acute Non-Lymphocytic Leukemia. Eur. J. Haematol. 1992; 48(2)87–92
   PubMed Web of Science ®Google Scholar
• Kuwazuru Y., Yoshimura A., Hanada S., Utsunomiya A., Makino T., Ishibashi K., Kodama M., Iwahashi M., Arima T., Akiyama S. Expression of the multidrug transporter P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance. Cancer 1990; 66(5)868–873
   PubMed Web of Science ®Google Scholar
• Holmes J.A., West R.R. The effect of MDR-1 geneex-pression on outcome in acute myeloblastic leukaemia. Br. J. Cancer 1994; 69(2)382–384
   PubMed Web of Science ®Google Scholar
• Farber C.M., Kanganis D.N., Liebes L.F., Silber R. Antioxidant enzymes in lymphocytes from normal subjects and patients with chronic lymphocytic leukemia: Increased glutathione peroxidase activity in CLL B lymphocytes. Br. J. Haematol. 1989; 72: 32–35
   PubMed Web of Science ®Google Scholar
• Robson C.N., Lewis A.D., Wolf C.R., Hayes J.D., Hall A., Proctor S.J., Harris A.L., Hickson I.D. Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione S-transferase activity. Cancer Res. 1987; 47: 6022–6027
   PubMed Web of Science ®Google Scholar
• Lewis A.D., Hickson I.D., Robson C.N., Harris A.L., Hayes J.D., Griffiths S.A., Manson M.M., Hall A.E., Moss J.E., Wolf C.R. Amplification and increased expression of alpha class glutathione S-transferase-encoding genes associated with resistance to nitrogen mustards. PNAS USA 1988; 85: 8511–8515
   PubMed Web of Science ®Google Scholar
• Ozols R.F., Louie K.G., Plowman J., Behrens B.C., Fine R.L., Dykes D., Hamilton T.C. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Biochem. Pharmacol. 1987; 36: 147–153
   PubMed Web of Science ®Google Scholar
• Puchalski R.B., Fahl W.E. Expression of recombinant glutathione-S-transferase it, Ya, or Ybl confers resistance to alkylating agents. Med. Sci. 1990; 87: 2443–2447
   Google Scholar
• Holmes J., Wareing C., Jacobs A., Hayes J.D., Padua R.A., Wolf C.R. Glutathione S-transferase pi expression in leukaemia: a comparative analysis with mdr-1 data. Br. J. Cancer 1990; 62: 209–212
   PubMed Web of Science ®Google Scholar
• Pegg A.E. Mammalian 06-alkylguanine-DNA alkyltrans-ferase: regulation and importance in response to alkylating and therapeutic agents. Cancer Res. 1990; 50: 6119–6129
   PubMed Web of Science ®Google Scholar
• Scudiero D.A., Meyer S.A., Clatterbuck B.E., Mattern M.R., Ziolkowski C. H. J., Day R.S. Sensitivity of human cell strains having different abilities to repair O6-methylguanine in DNA to inactivation by alkylating agent including chloroethylnitrosourea. Cancer Res. 1984; 44: 2467–2474
   PubMed Web of Science ®Google Scholar
• Gerson S.L., Trey J.E., Miller K., Berger N.A. Comparison of O6-Alkylguanine-DNA Alkyltransferase Activity based on Cellular DNA Content in Human, Rat and Mouse Tissues. Carcinogenesis 1986; 7(5)745–749
   PubMed Web of Science ®Google Scholar
• Buser K., Joncourt F., Redmond S. M. S., Altermatt H.J., Rossier J., Hanggi W., Cerny T. Drug resistance parameters in patients with breast and ovarian cancer. Eur. J. Cancer 1991; 27(Suppl, 2)210
   PubMedGoogle Scholar
• Adamson P.C., Poplack D.G. Pharmacologic factors involved in the response to chemotherapy: apparent versus intrinsic drug resistance. Drug resistance in Leukemia and Lymphoma. The Clinical Value of Laboratory Studies, G. J. L. Kapsers, R. Pieters, P.R. Twentyman, L.M. Weisenthal, A. J. P. Veerman. Harwood Academic Publishers. 1993; 33–39
   Google Scholar
• Raderer M., Scheithauer W. Clinical trials of agents that reverse multidrug resistance-A literature review. Cancer 1993; 72(12)3553–3563
   PubMed Web of Science ®Google Scholar